PowerPoint Presentation

croatiandestructiveΒιοτεχνολογία

9 Δεκ 2012 (πριν από 4 χρόνια και 9 μήνες)

167 εμφανίσεις

-
$20
$40
$60
US
$
B

45%

41%

13%

2%

Ontario
Quebec
West
Maritimes
Rank
Company
Total Exenditure
$B
1
Johnson & Johnson
$1.70
2
AstraZeneca
$1.70
3
Pfizer
$1.55
4
Teva
$1.40
5
Apotex
$1.24
6
Merk
$1.05
7
Novartis
$1.03
8
GlaxoSmithKline
$0.94
9
Abbot
$0.86
10
Bristol-Myers Squibb
$0.75
Sector Primer


Canadian
Private Healthcare

Overview

Source: Industry Canada.

Private participation in the Canadian healthcare market
refers to involvement of non
-
government entities.
Healthcare is largely
publicly
funded, but the majority of
services
are provided privately. Estimates place the amount
of services provided at ~75% of all services delivered.


~28% of Canadians’ healthcare is funded through the
private sector as they are partially or not covered at all
by Canadian Medicare


Most physician services are provided through private,
owner
-
operated small businesses; their services are
contracted by the state


~57.8% work in a private office or clinic

Private Sector

For Profit
Entities

Non
-
Profit
Entities

Individuals
/Families

Source: Jay
Makarenko
. Canada’s Healthcare System.

Pharmaceuticals

Distribution of R&D Expenditures


Brand name co.’s account for 78% of sales and 52% of
volume; generics accounting for the rest


The pharmaceutical industry is second after IT with
respect to total R&D spending


26 pharmaceutical firms are listed in the top 100
R&D spending firms in Canada

Medical Technology


Market valued at ~$6.4 billion with a CAGR of 2%
from 2000 to 2008
(Global Data 2009)


Medical device development industry consisted of
~1000 firms at year end 2011


~90% of facilities are Canadian owned; larger ones
dominated by foreign ownership


Average facility employment small at ~23 people


Canada has the lowest cost index of G
-
7 nations


Country
Index
U.S. = 100
Canada
95.2
France
97.6
U.K.
98.4
Italy
98.6
United States
100
Germany
102.7
Japan
108.4
Manufacturing Cost Index

$0.0
$2.0
$4.0
$6.0
2005
2006
2007
2008
2009
Device
Value ($B)

Exports
Imports
Import and Export Value


Canada imports a high degree of medical devices, with
>50% coming from the U.S. and ~24% from Germany,
Switzerland, China, and Ireland

Medical Tourism


Medical tourism is a growing global trend with an
estimated global market value of ~US$40B in 2010


I
n 2008
-
2009 Canadian government funded over
$220MM in services, or ~41,000 patients sent abroad


In a 2009 survey 60% of Canadians were willing to
travel if services were covered under insurance; 31% if
services were self
-
paid


Inbound U.S. medical tourism is a growing market

Source: Deloitte


Evolving Medical Tourism

U.S. Global Outbound Spending

Prepared by Queen’s Global Markets,
a Commerce Society Partner

8.0%
12.0%
16.0%
2005
2006
2007
2008
2009
2010
% of GDP

Canada
US
$300.3,
36%

$263.9,
31%

$23.5, 3%

$47.8, 6%

$95.0,
11%

$106.6,
13%

U.S.
Europe
Canada
Latin America
Japan
Asia, Africa,
Australia
Sector Primer


U.S.
Private Healthcare

Overview

-
5,000
10,000
15,000
20,000
25,000
30,000
35,000
Members (in 000’s)

Source: Atlantic Information Service, Directory of Health Plans, 2009.

Medical Insurance


Medical
insurance companies are ubiquitous in the
United States due to the

lack
of universal
healthcare


Method of pooling
risk

so that the cost is
distributed among many
people


Current low interest rate environment is leading to a
loss
in profitability
as returns are
less than
actuarial
rates


Signed into law in March 2010 it represents the most
significant regulatory change in U.S. healthcare since
Medicare & Medicaid


Aimed at decreasing # of
uninsured

Americans by
offering subsidies and tax credits to employers and
individuals to increase coverage rates


Expected to actually
decrease
employer
-
sponsored
enrollment but increase Medicaid/CHIP enrollment

Top 10 Health Insurance Companies

Patient Protection & Affordable Care
Act (aka
Obamacare
)

Medical Tourism

-
$20,000
$40,000
$60,000
Cost (US$)


Similar to Canada the high cost of care domestically is
promoting patients to seek treatment abroad


Outbound value of US visits ~US$2.3B per year

Cost of Knee Surgery

Source: Medical Tourism Association.

Pharmaceuticals


World’s largest market valued at ~US$300 B


U.S. firms conduct 80% of the world’s development in
biotechnology and in 2010 spent US$67 B on R&D


~1,552 companies manufacturing and developing
biological products
(2007 Economic Census)


~420,000 people employed in the sector, but has been
declining since a peak in 2007


Largest export markets are Germany, Netherlands and
the UK, totalling ~40% of U.S. exports


Medical Technology


World leader and is the industry’s largest consumer,
with the market valued at ~$110 B in 2010


Employs 1.8 million people


Exports valued at US$38 B by Department of
Commerce (DOC) and imports at US$32 B


Key markets are electro medical, irradiation, surgical
and dental equipment


Source: Select USA &
AdvaMed
.

Employment
Personal Income
Value Added
Output
Impact
1,887,000


$113.59
$191.68
$381.62
US Sales VS Global Sales

Source: International Trade Administration Office, Health & Consumer Goods, 2010..

Provision of healthcare in the United states is dominated
by
private enterprise
. Healthcare expenditure is very high in
the U.S. with ~48% funded by government, as compared
to ~70% in Canada (
OECD Health Data 2012).

U.S. VS Canadian Expenditure

Prepared by Queen’s Global Markets,
a Commerce Society Partner